ArticleBMJ open2025

Clinical study of adebrelimab in combination with apatinib and irinotecan for PD-1 inhibitor-ineffective advanced-stage gastric cancer: study protocol for a single-arm, single-centre, exploratory trial.

Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.